Robert M. Centor, MD; Rodney A. Hayward, MD
Disclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. Hayward has disclosed no conflicts of interest.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Proctor & Gamble, Pfizer, and Johnson & Johnson.
Audio. Annals On Call - Improving Estimation of Cardiovascular Risk: In this episode of Annals On Call, Dr. Centor discusses an update of the pooled cohort equations used to estimate atherosclerotic cardiovascular disease risk with Dr. Rodney Hayward. Dr. Hayward was a co-investigator on a recent study that updated the equations to improve prediction in sex and race subgroups.
Other Audio Options: Download MP3
Centor RM, Hayward RA. Annals On Call - Improving Estimation of Cardiovascular Risk. Ann Intern Med. 2018;169:OC1. doi: https://doi.org/10.7326/A18-0007
Download citation file:
Published: Ann Intern Med. 2018;169(9):OC1.
Cardiology, Coronary Risk Factors, Prevention/Screening.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use